A single bout of low-frequency electroacupuncture (EA) causing muscle contractions increases wholebody glucose uptake in insulin-resistant rats. We explored the underlying mechanism of this finding and whether it can be translated into clinical settings. Changes in glucose infusion rate (GIR) were measured by euglycemichyperinsulinemic clamp during and after 45 min of low-frequency EA in 21 overweight/obese women with polycystic ovary syndrome (PCOS) and 21 controls matched for age, weight, and body mass index (experiment 1) and in rats receiving autonomic receptor blockers (experiment 2). GIR was higher after EA in controls and women with PCOS. Plasma serotonin levels and homovanillic acid, markers of vagal activity, decreased in both controls and patients with PCOS. Adipose tissue expression of pro-nerve growth factor (proNGF) decreased, and the mature NGF/proNGF ratio increased after EA in PCOS, but not in controls, suggesting increased sympathetic-driven adipose tissue metabolism. Administration of a-/b-adrenergic receptor blockers in rats blocked the increase in GIR in response to EA. Muscarinic and dopamine receptor antagonist also blocked the response but with slower onset. In conclusion, a single bout of EA increases whole-body glucose uptake by activation of the sympathetic and partly the parasympathetic nervous systems, which could have important clinical implications for the treatment of insulin resistancenervous system activation mediates the increase in whole-body glucose uptake in response to electroacupuncture. FASEB J. 31, 3288-3297 (2017). www.fasebj.org KEY WORDS: glucose homeostasis • polycystic ovary syndrome • insulin resistance • muscle contraction
Physical exercise has beneficial effects on metabolic dysfunctions, including improved energy balance, reduced adiposity, and regulation of key signaling molecules in skeletal muscle and adipose tissue (1) . A single bout of exercise induces rapid changes in skeletal muscle and adipose tissue, and these changes have been directly related to muscle contractions. Muscle contractions cause an immediate increase in glucose uptake in skeletal muscle and adipose tissue by activating glucose transporter (GLUT)-4 translocation to the cell membrane in an insulinindependent manner (2) . This process is considered to be the main mechanism for the acute effect of physical exercise on glucose transport. Accumulating evidence suggests that the sympathetic nervous system also plays an important role in the regulation of glucose homeostasis (3) . For example, stimulation of hepatic sympathetic nerves induces rapid and marked release of glucose from the liver, stimulation of pancreatic sympathetic nerves causes a decrease in insulin secretion and stimulation of ABBREVIATIONS: 5HIAA, 5-hydroxyindoleacetic acid; BMI, body mass index; CV, coefficient of variability; DOPAC, 3,4-dihydroxyphenylacetic acid; EA, electroacupuncture; GIR, glucose infusion rate; GLUT, glucose transporter; HOMA-IR, homeostatic model assessment; HVA, homovanillic acid; mNGF, mature nerve growth factor; NGF, nerve growth factor; PCOS, polycystic ovary syndrome; proNGF, pro-nerve growth factor; SI clamp , sensitivity index clamp sympathetic nerves innervating adipose tissue causes lipolysis. These regulatory changes are important for handling the increased energy requirement during exercise.
Acupuncture with low-frequency electrical stimulation causing muscle contraction [electroacupuncure (EA)], activates afferent nerve fibers (Ad fibers and C fibers) (4) and efferent sympathetic nerve fibers in the same segmental innervation during stimulation (5) (6) (7) (8) . Further, low-frequency EA has been shown to stimulate dopamine secretion that modulates vagal activity and controls inflammation (9) , and it has been shown to modulate the release of endogenous opioids, which in turn might participate in the regulation of glucose metabolism (10, 11) . Thus, EA induces changes in skeletal muscle and adipose tissue signaling pathways similar to exercise-induced muscle contractions (12, 13) , and it has the potential to ameliorate various metabolic disorders associated with altered autonomic activity and insulin resistance (14) .
A single bout of low-frequency EA increases wholebody glucose uptake during and after stimulation in both controls and insulin-resistant rats (15) . However, there is only limited evidence in support of the effectiveness of EA for improving glucose homeostasis or insulin sensitivity during and after stimulation in humans (16) , and there is no study evaluating the effect in insulin-resistant subjects. Clinically, EA can be a useful way of assisting muscle contraction for those who have difficulties performing voluntary exercise. However, it remains to be determined whether the rapid increase in glucose uptake by a single bout of EA in an insulin-resistant rodent model can be extrapolated to overweight and obese women with polycystic ovary syndrome (PCOS). PCOS is the most common endocrine and metabolic disorder among women and is associated with obesity, insulin resistance, and impaired fertility (17) . Further, it remains to be determined via which pathways the effect of EA is mediated.
We aimed to test the hypothesis that a single bout of low-frequency EA increases whole-body glucose uptake in overweight and obese women with and without PCOS. We hypothesized that adipose tissue expression of pro-nerve growth factor (proNGF) and mature NGF (mNGF), which are regulators of sympathetic nerve activity (18, 19) , are modified and that plasma catecholamines and their metabolites are decreased by low-frequency electroacupuncture.
Because it has recently been demonstrated that the autonomic nervous system is activated to counteract decreased blood glucose (20, 21) , we tested the hypothesis that increased glucose uptake by EA is mediated via activation of the autonomic nervous system and the opioid system.
MATERIALS AND METHODS

Experiment 1
The human experiment was conducted in accordance with the Declaration of Helsinki and was approved by the regional ethics board at the Sahlgrenska Academy at the University of Gothenburg, Sweden (Dnr 520-11) (Fig. 1A) . The study was registered October 6, 2011, at ClinicalTrials.gov (NCT01457209) [U.S. National Institutes of Health (NIH), Bethesda, MD, USA] before the start of recruitment. All participants gave oral and written informed consent and were recruited through advertisements in local newspapers and in frequently visited places in the community between October 2011 and December 2013 in the Västra Götaland Region, Sweden.
Participants
Twenty-one overweight or obese women with PCOS and 21 controls matched for age, weight, and body mass index (BMI) were included. Inclusion criteria for the controls were 18-38 yr old, BMI .25 to ,35, regular menstrual cycles of 28 6 2 d, and normal ovarian morphology. Controls were excluded if they showed signs of hyperandrogenism (Ferriman-Gallwey score .4). Women with PCOS were diagnosed according to the Rotterdam criteria (22) fulfilling 2 of 3 criteria: ultrasound-verified polycystic ovaries ($12 follicles of 2-9 mm and/or ovarian volume $10 ml in 1 or both ovaries), oligomenorrhea (.35 d between, or ,6 menstruations in the past year), amenorrhea (absence of menstrual bleedings in the past 90 d), or clinical signs of hyperandrogenism (acne or hirsutism, Ferriman-Gallwey score $8) (23). The International Physical Activity Questionnaire estimated physical activity.
Participants reported to the laboratory in the morning after an overnight fast, anthropometrics were measured and BMI and waist-hip ratio (the ratio of waist and hip circumferences) were calculated. Basal blood samples were taken and homeostatic model assessment (HOMA-IR) [(fasting insulin (mU/ml) 3 fasting glucose (mM)/22.5)] and C-peptide index were calculated at baseline.
Euglycemic-hyperinsulinemic clamp
The euglycemic-hyperinsulinemic clamp was performed as described previously (24) at menstrual cycle d 1-10. In ameno-/oligomenorrrheic women, the experiment was performed irrespective of cycle day. Body surface area was calculated using the Mosteller formula. Insulin was continuously infused (40 mU/m 2 /min) for 120 min to reach steady state, and plasma glucose concentrations were measured every 10 min during the first 90 min of infusion, and thereafter every 5 min throughout the clamp. Steady state was defined as the last 30 min of the clamp. Euglycemia (5 mM) was achieved by infusing 20% glucose (1.1 M), and it was kept at 5 mM by adjusting the glucose infusion rate (GIR). At steady state a needle biopsy of subcutaneous abdominal adipose tissue was obtained under local anesthesia (Xylocain, AstraZeneca AB, Sweden) and snap frozen.
Blood samples for assessing plasma insulin were taken at baseline and at 60, 90, 100, 110, and 120 min during steady state; at 25, 35, and 45 min during acupuncture; and at 30, 40, 50, and 60 min after stimulation. Blood samples for assessing C-peptide were taken at baseline and the final 10 min of steady state, at 25 and 35 min during electroacupuncture, and at 40 min after stimulation. The clamp continued during and for 60 min after the end of electroacupuncture.
The GIR (mg/kg/min) during steady state, during the last 20 min of stimulation, and during the last 30 min after EA (poststimulation) was used to measure whole-body glucose uptake (M value). Insulin sensitivity index clamp (SI clamp ) was calculated according to Bergman et al. (25) at the same time points.
Electroacupuncture
We used a Western style of acupuncture (26) . In brief, acupuncture needles were placed bilaterally in the abdominal muscle, in the quadriceps muscles, and in the muscles below the medial side of the knee, all in somatic segments corresponding to the innervation of the ovaries and pancreas. Needles were also placed in the hand. The needles were inserted to a depth of 15-40 mm and stimulated by manual rotation when inserted to evoke needle sensation (de qi). Needle placement and stimulation are presented in Table 1 . Immediately after 45 min of electroacupuncture, a second needle biopsy of subcutaneous abdominal adipose tissue was collected.
Experiment 2
The animal experiment was approved by the Animal Ethics Committee of the University of Gothenburg, Sweden, and followed the Guide for the Care and Use of Laboratory Animals (NIH). Female Wistar rats (Charles River, Sulzfeld, Germany) arrived at 13 wk of age, and were fed ad libitum with standard rat chow (Teklad Global Diet; Harlan, Rossdorf, Germany) ( Fig. 1B) . Rats were tested for the presence of an estrous cycle as determined by vaginal smears and randomly divided into a no-stimulation group and an EA group. Because the purpose of this study was to investigate the pathways through which acupuncture increases whole-body glucose uptake, the groups were further divided into rats receiving nonselective receptor blocking agents or saline as a control.
A subset of PCOS rats received EA in combination with phentolamine and propranolol (Supplemental Data).
Euglycemic-hyperinsulinemic clamp
The clamp was performed in animals under anesthesia (15) . Insulin (Actrapid, Novo Nordisk, Denmark) was continuously infused at 8 mU/kg/min, and glucose was infused to maintain a blood glucose level of 6 mM. Blood glucose levels were measured every 5 min. Insulin sensitivity was quantified as the GIR (mg/kg/min). The final GIR value during steady state was set to 1, and the fold change during EA and the poststimulation period was calculated.
Electroacupuncture
At steady state, 2 acupuncture needles (Hegu Svenska AB, Landsbro, Sweden; 0.20 3 15 mm) were placed in the rectus abdominis muscle, which corresponds to the acupuncture points ST27-29, and 2 needles were placed in the triceps surae muscle bilaterally, which corresponds to SP6 and -9. All acupuncture points were in somatic segments corresponding to the innervation of the pancreas and ovaries. The needles were attached to an electrical stimulator (CEFAR ACU II; Cefar-Compex Scandinavia, Malmö, Sweden) and stimulated with low frequency (2 Hz) at an intensity high enough to evoke muscle twitches, which varied from 0.8 to 2.2 mA, due to receptor adaptation. Responders to EA were identified as those with .15% increase in GIR at 25 min of stimulation, and blocking agents were administered to these rats at 30 min. A bolus of naltrexone (10 mg/kg), phentolamine (5 mg/kg), propranolol (1 mg/kg), phentolamine and propranolol, atropine (1 mg/kg), butaclamol (2 mg/kg), or saline was given. After the bolus, a continuous infusion of atropine (0.5 mg/kg), Responders i.e. GIR >15% at 25 min was given blocking agent(s) i.v.at 30 min
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butaclamol (1 mg/kg), phentolamine (7 mg/kg/h), propranolol (0.5 mg/kg/h), both phentolamine and propranolol or saline was administered. After the 45 min of electroacupuncture, the clamp and blocking continued for another 60 min. Animals in the nostimulation group underwent the same procedure as those in the EA group but with a wooden toothpick that touched the skin.
Laboratory analyses Plasma glucose was measured by One Touch Ultra2 (LifeScan, West Chester, PA, USA). Insulin was analyzed at an accredited laboratory. Serum insulin was measured with immunometric 2-step sandwich method (Advia Centaur Insulin Ready Pack; Bayer HealthCare, Leverkusen, Germany) where 2 antibodies are used: antiinsulin (Lite Reagent, Siemens, Upplands Väsby, Germany) and a monoclonal mouse anti-insulin antibody (Solid Phase; Siemens) to initiate a chemiluminescence reaction, the intraassay coefficient of variability (CV%) was 10%. Serum C-peptide was measured with a human diabetes C-peptide magnetic bead set (Bio-Rad, Hercules, CA, USA), the intraand interassay CV% was 5 and 4%, respectively. Plasma noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), serotonin, and 5-hydroxyindoleacetic acid (5HIAA) were measured on a split-fraction HPLC-ED system (27) . Serum testosterone, estradiol, and progesterone were measured by gas chromatography-tandem mass spectrometry (28) .
Adipose tissue extraction and ELISA Adipose tissue was homogenized in ice-cold lysis buffer [20 mM Tris (pH 7.4), 150 mM NaCl, 10% glycerol, 1 mM EDTA (pH 8.0), 20 mM NaF, 30 mM sodium pyrophosphate (Na 4 P 7 O 2 )], and protease and phosphatase inhibitor cocktails (P8340, P5276, and P0044; Sigma-Aldrich, Stockholm, Sweden). The homogenized tissue samples were centrifuged at 3000 g for 6 min at 4°C, and the lower phase was collected. Five volumes of ice-cold detergent mix (6% NP40, 0.6% SDS, and 1.5% NaDOC) were added, followed by shaking on ice for 45 min and centrifugation at 3000 g for 20 min at 4°C. The protein concentration was quantified by the Bradford assay. mNGF and proNGF were detected and quantified using MAB5260Z clone 27/21 and EP1318Y antibodies (Merck Millipore, Billerica, MA, USA) in a homemade sandwich ELISA (29) .
Statistical analyses
Data are presented as means 6 SEM, and Fisher's permutation test was used to assess differences between women with PCOS and controls at steady state, during electroacupuncture, and after stimulation. Fisher's test for paired comparisons was used to analyze changes between steady state and during EA and between steady state and poststimulation in women with PCOS and controls. Fisher's permutation test and Fisher's test for paired comparisons are nonparametric tests and are not to be confused with Fisher's exact test (30) . In rats, changes in GIR during steady state, electroacupuncture, and after stimulation within each group and between the groups were compared with repeatedmeasures 2-way ANOVA followed by the Bonferroni post hoc test. Statistical analyses were performed with SPSS software (v.21.0; SPSS, Chicago, IL, USA), and a value of P # 0.05 was considered significant. Acupuncture needles (0.25 3 30 or 0.30 3 50 mm) were placed in the acupuncture points listed, in somatic segments corresponding to the innervation of the ovaries and pancreas. All needles were stimulated manually when inserted, and thereafter every 10th minute or electrically with low-frequency (2 Hz) for 45 min. The intensity was adjusted to produce local muscle contractions without pain or discomfort. Acupuncture was delivered by a therapist educated in Western medical acupuncture and with over 25 yr of experience. C, cervical vertebra; CV, conception vessel; L, lumbar vertebra; LI, large intestine; LR, liver; PC, pericardium; S, sacral vertebra; SP, spleen; ST, stomach; Th, thoracic vertebra.
RESULTS
Baseline characteristics
Baseline characteristics are presented in Table 2 . There was no difference in age, weight, and BMI between women with and without PCOS. Women with PCOS had higher serum testosterone, number of antral follicles, and FG score (P , 0.001 for all parameters) vs. controls. Oligo-/amenorrhea was recorded in 18 women with PCOS, whereas all controls had regular cycles. Fasting insulin and HOMA-IR was nonsignificantly higher (P = 0.068 and P = 0.061, respectively), fasting C-peptide and C-peptide index were higher (P = 0.028 and P = 0.008), and fasting glucose was lower (P = 0.01). Fourteen women with PCOS and 10 controls had a HOMA-IR .2.0, which is indicative of insulin resistance. There was no difference in the overall total physical activity between women with PCOS and controls [2219 6 1820 vs. 1887 6 2272 METmin/wk (P = 0.675)].
Changes in whole-body glucose uptake in women
The GIR was higher during the poststimulation period compared with steady state in patients with PCOS (P = 0.019) and controls (P = 0.003) ( Fig. 2A) , whereas calculated insulin SI clamp , taking insulin levels before and during the clamp into account, was higher during the poststimulation period, only in patients with PCOS (P = 0.045; Fig. 2B ). There were no significant within-group changes in the GIR and SI clamp during electroacupuncture, which might be explained by decreased insulin clearance or increased insulin secretion as evidenced by increased insulin concentration in controls and increased C-peptide concentrations in patients with PCOS during EA (Fig.  2C, D) . There were no significant differences in GIR or SI clamp between case and control subjects during or after electroacupuncture.
Because the effect of electroacupuncture, at least in part, has been shown to be mediated via changes in the autonomic nervous system, dopamine and its metabolites were measured. Serotonin and HVA decreased in controls and patients with PCOS (Fig. 3A, B) immediately after a single bout of electroacupuncture, indicating modulation of the vagal system. The plasma levels of dopamine, noradrenalin, and DOPAC were below the detection limit.
The expression of pro-NGF was decreased ( Fig. 3C ) and the mNGF/proNGF ratio was increased ( Fig. 3E ) in adipose tissue immediately after EA only in women with PCOS ( Fig. 3C-E) .
The decrease in serotonin and HVA by EA indicates modulation of the parasympathetic nervous system. Also, the increase in mNGF/proNGF ratio indicates that EA modulates the sympathetic nervous system. Therefore, we investigated whether the increased whole-body glucose uptake by EA could be inhibited by blocking agents for sympathetic, parasympathetic, dopamine, and opioid receptors in rats.
Pathways by which EA increases glucose uptake in rats
The GIR in the no-stimulation and saline-stimulated rats did not change during the clamp (Fig. 4A) . In the EA and saline group, the mean GIR was increased during stimulation (P , 0.001) and poststimulation (P , 0.001) compared to steady state and was higher than in the no-stimulation and saline group. 
Opioid receptor blocker
Administration of naltrexone did not block the increased GIR induced by a single bout of EA (P , 0.01) and did not affect GIR in the no-stimulation group (Fig. 4B ).
Dopamine receptor blocker
Blocking with butaclamol returned the GIR values to steady-state levels in the poststimulation period in the low-frequency EA group (P , 0.001; Fig. 4C ). Administration of butaclamol to the no-stimulation group decreased GIR in the poststimulation period compared with steady state (P , 0.05), but it did not differ from the EA and butaclamol or the no-stimulation and saline groups.
Muscarinic receptor blocker
Blocking with atropine returned the GIR values to steady-state levels in the poststimulation period in the low-frequency EA group (P , 0.001; Fig. 4D ). Administration of atropine to the no-stimulation group decreased GIR in the poststimulation period compared with steady state (P , 0.001), but did not differ from the EA and atropine or no-stimulation and saline groups.
a-Adrenergic receptor blocker
Phentolamine (a nonselective a-receptor antagonist) returned the increased GIR values to steady-state levels in the EA group (P , 0.01; Fig. 4E ). GIR was below steady-state levels during the poststimulation period (P , 0.05) and differed from the no-stimulation phentolamine group. Phentolamine did not affect GIR in the no-stimulation group.
b-Adrenergic receptor blocker
Propranolol (a nonselective b-receptor antagonist) returned the increased GIR values to steady-state levels in the EA group (P , 0.01), and these levels did not differ from the no-stimulation propranolol group during the poststimulation period (Fig. 4F ). However, GIR values in the poststimulation period were higher than steady-state levels (P , 0.05). Propranolol did not affect GIR in the no-stimulation group.
Combined phentolamine and propranolol returned the increased GIR values to steady-state levels in the poststimulation period (P , 0.01; Fig. 4G ) but did not significantly affect GIR in the no-stimulation group.
Administration of combined phentolamine and propranolol to PCOS rats in the EA group resulted in an immediate return of GIR values to steady-state levels in the poststimulation period (Supplemental Fig. 1 ).
DISCUSSION
The effect of low-frequency EA on whole-body glucose uptake is largely unknown. In this study, a single bout of EA resulted in a significant increase in insulin-stimulated glucose uptake in overweight women with and without PCOS. Also, EA modulates circulating serotonin and HVA levels in case and control subjects, whereas adipose tissue markers of sympathetic nerve activity were only increased in women with PCOS. In rats, the increased glucose uptake was completely blocked by administration of inhibitors of sympathetic nerve activity and partially blocked by administration of inhibitors of parasympathetic nerve activity.
Physical exercise with muscle contractions is the first line of therapy to improve insulin sensitivity in persons with impaired glucose tolerance and compensatory hyperinsulinemia, but the use of complementary and alternative medicine is increasing and may serve as an adjunct to conventional medical care (31) . We hypothesized that low-frequency EA that causes muscle contractions would alter metabolic stress by activating the autonomic nervous system and that the effect would be stronger in women with PCOS than in healthy controls. The reason for this is that we have previously demonstrated that lowfrequency EA modulates sympathetic nerve activity in a rat model of PCOS (32) and in control rats (7, 8) , as well as in women with PCOS (33). The GIR increased after EA stimulation, but not significantly during stimulation despite slightly higher insulin concentrations in this period. A similar tendency with increased insulin levels was seen in a previous human study using transcutaneous lowfrequency electrical stimulation with electrodes placed on the skin instead of needles inserted into the muscle (34) . During the euglycemic-hyperinsulinemic clamp, insulin infusion is set to a fixed rate and the GIR is adjusted to keep blood glucose stable. The increased insulin levels seen during EA must therefore be due to increased endogenous production of insulin or decreased clearance of insulin. C-peptide levels were increased in patients with PCOS during stimulation, suggesting that EA triggers insulin release. Insulin levels increased in controls during stimulation, and we speculate that insulin clearance might be affected in controls whereas insulin production is more affected in patients with PCOS.
The effect of EA involves modulation of sympathetic nerve activity (7, 33) and vagal activity (9) . Therefore, we analyzed adipose tissue protein expression of NGF, which is known to be a regulator of sympathetic innervation of adipose tissue. Both mNGF and proNGF activate the tyrosine kinase A receptor in supporting sympathetic activity (35) , and mNGF regulates adipocyte metabolism in vitro (36) . In our study, a single bout of EA decreased adipose tissue proNGF and increased the mNGF/proNGF ratio in patients with PCOS, indicating that mNGF activity is stimulated by EA in combination with hyperinsulinemia. It has been reported that proNGF acts as an inducer of sympathetic denervation in peripheral tissues (37, 38) . Our data are consistent with a possible increased conversion of proNGF into mNGF (39) , which would support sympathetic activity far beyond the stimulation period with possible long-lasting beneficial effects on adipose tissue metabolism (36, 40) and glucose uptake (26) . Serotonin affects glucose homeostasis and insulin resistance via vagal afferent serotonergic neurons and receptors in peripheral tissue. It is increased in type 2 diabetes (41), and HVA is responsive to changes in blood glucose (42) . It is noteworthy, therefore, that serotonin and HVA decreased in response to EA in both controls and patients with PCOS, indicating that increased glucose uptake is mediated via modulation of the vagal system.
Exercise can increase the glucose uptake rate by either insulin-independent or -dependent mechanisms. Lowfrequency EA lowers plasma glucose and increases plasma insulin in normal and type 2 diabetic rats, but not in type 1 diabetic rats, and it can therefore be considered insulin dependent (5, 10) . However, the increased response to exogenous insulin after electrical stimulation seen in both types 1 and 2 diabetic rats indicates an insulin-sensitizing effect (43, 44) , possibly mediated by increased GLUT4 concentrations in muscle and adipose tissue (10, 44) .
We previously demonstrated that a single bout of EA in rats is superior to manual stimulation of the needles, but they are equally effective during the poststimulation period, indicating that it is the activation of sensory afferents rather than muscle contractions per se that causes the observed changes (15) . Here, we show that the increased glucose uptake in rats is mediated by activation of sympathetic nerves because blocking adrenergic receptors reverses the increased glucose uptake. These results are supported by in vitro studies demonstrating that a 1 -and b 2 -receptor agonists can stimulate GLUT4 translocation in skeletal muscle and white adipose tissue (45) . Further, adrenergic stimulation of aand b-adrenoceptors increases glucose uptake in rodents and antagonists can block this effect.
Electroacupuncture modulates the production of catecholamines in the adrenal glands, leading to increased serum levels of dopamine and noradrenaline in rodents (9) , this effect is completely blocked by the dopamine receptor antagonist butaclamol. We show that butaclamol reverses the increased glucose uptake in rats, suggesting that all 3 catecholamines may mediate the enhanced glucose uptake during and after electroacupuncture.
When blood glucose levels fall below the normal basal values, parasympathetic activity stimulates glucagon secretion as a first response to restore normoglycemia (46) . However, parasympathetic innervation of the pancreatic islet is also involved during hyperglycemia in the potentiation of insulin secretion through the release of acetylcholine, which binds to muscarinic receptors on pancreatic b cells. In the current study, the increased glucose uptake in response to EA in rats is partly mediated by activation of parasympathetic nerves because blocking muscarinic receptors with atropine reverses the increased glucose uptake, but with a slower onset compared with adrenergic receptor blockers. These results support previous findings showing that EA can improve glucose tolerance through cholinergic nerve activation in rats, an effect that is modulated by atropine (43) . Phentolamine's primary action is vasodilatation, which lowers arterial blood pressure and induces tachycardia. Propranolol also lowers blood pressure, but its antihypertensive effect is less potent (47) . We did not monitor blood pressure in this study, but an obvious question is if possible changes in blood pressure contributed to the decrease in GIR after administration of autonomic blockers in electroacupuncture-stimulated rats. We do not think that any such unspecific effect is important, because we did not see any effect on GIR when the aor b-adrenergic blockers were given to rats not receiving any acupuncture, which indicates that aor b-adrenergic blockers do not affect glucose uptake at steady state via unspecific effects on blood pressure.
Administration of naltrexone did not block the electroacupuncture-induced increase in GIR. This result does not support previous observations showing that the increased glucose uptake is mediated via the endogenous opioid system in rats (10) , resulting in activation of specific opioid receptors (48) , and that this effect is partly blocked by naloxone, a m-opioid receptor antagonist (10, 11) . This difference may be due to the rather short-term stimulatory effect b-endorphin seems to exert on the pancreas (49) .
In summary, we demonstrate here that a single bout of electroacupuncture causes an immediate increase in whole-body glucose uptake in overweight and obese women, both controls and women with PCOS, and this effect is in part mediated via activation of the sympathetic and parasympathetic nervous system but not by the opioid receptor system. These results could have important clinical implications for the nonpharmacological treatment of insulin resistance.
